It is now well understood that once in contact with biological fluids, nanoscale objects lose their original identity and acquire a new biological character, referred to as a protein corona. The protein corona changes many of the physicochemical properties of nanoparticles, including size, surface charge, and aggregation state. These changes, in turn, affect the biological fate of nanoparticles, including their pharmacokinetics, biodistribution, and therapeutic efficacy. It is progressively being accepted that even slight variations in the composition of a protein source (e.g., plasma and serum) can substantially change the composition of the corona formed on the surface of the exact same nanoparticles. Recently it has been shown that the protein corona is strongly affected by the patient's specific disease. Therefore, the same nanomaterial incubated with plasma proteins of patients with different pathologies adsorb protein coronas with different compositions, giving rise to the concept of personalized protein corona. Herein, we review this concept along with recent advances on the topic, with a particular focus on clinical relevance.

Corbo, C., Molinaro, R., Tabatabaei, M., Farokhzad, O., Mahmoudi, M. (2017). Personalized protein corona on nanoparticles and its clinical implications. BIOMATERIALS SCIENCE, 5(3), 378-387 [10.1039/c6bm00921b].

Personalized protein corona on nanoparticles and its clinical implications

Corbo, C;
2017

Abstract

It is now well understood that once in contact with biological fluids, nanoscale objects lose their original identity and acquire a new biological character, referred to as a protein corona. The protein corona changes many of the physicochemical properties of nanoparticles, including size, surface charge, and aggregation state. These changes, in turn, affect the biological fate of nanoparticles, including their pharmacokinetics, biodistribution, and therapeutic efficacy. It is progressively being accepted that even slight variations in the composition of a protein source (e.g., plasma and serum) can substantially change the composition of the corona formed on the surface of the exact same nanoparticles. Recently it has been shown that the protein corona is strongly affected by the patient's specific disease. Therefore, the same nanomaterial incubated with plasma proteins of patients with different pathologies adsorb protein coronas with different compositions, giving rise to the concept of personalized protein corona. Herein, we review this concept along with recent advances on the topic, with a particular focus on clinical relevance.
Articolo in rivista - Articolo scientifico
protein corona;
English
2017
5
3
378
387
reserved
Corbo, C., Molinaro, R., Tabatabaei, M., Farokhzad, O., Mahmoudi, M. (2017). Personalized protein corona on nanoparticles and its clinical implications. BIOMATERIALS SCIENCE, 5(3), 378-387 [10.1039/c6bm00921b].
File in questo prodotto:
File Dimensione Formato  
Biomaterials Science Corbo et al 2017.pdf

Solo gestori archivio

Tipologia di allegato: Author’s Accepted Manuscript, AAM (Post-print)
Dimensione 4.23 MB
Formato Adobe PDF
4.23 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
c6bm00921b.pdf

Solo gestori archivio

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 4.23 MB
Formato Adobe PDF
4.23 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/217916
Citazioni
  • Scopus 220
  • ???jsp.display-item.citation.isi??? 210
Social impact